They work by mimicking the GLP-1 hormone, which is produced in the small intestine, in effect, tricking the body into slowing digestion, releasing more insulin and reducing appetite, hunger and ultimately the amount of food consumed
New information about the complex etiology of this multi-faceted skin illness is being uncovered by ongoing research [28]
Previous studies have explored the effect of antibiotics on gut microbiota in animal models and in human prospective cohorts 8,9
Addressing these and other vital clinical questions will require additional investment in basic, translational, clinical and implementation research. They conclude: The management of hyperglycaemia in type 2 diabetes has become extraordinarily complex with the number of glucose-lowering medications now available
Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC)